- Home
- UPXI vs INO Comparison
UPXI vs INO Comparison
Compare UPXI & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPXI | INO |
|---|---|---|
| Founded | 2018 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.9M | 116.1M |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | UPXI | INO |
|---|---|---|
| Price | $1.98 | $1.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $6.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 4.1M | 1.8M |
| Earning Date | 02-13-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.85 | N/A |
| Revenue | ★ $20,694,575.00 | $182,337.00 |
| Revenue This Year | $141.57 | N/A |
| Revenue Next Year | $14.83 | $23,060.18 |
| P/E Ratio | $1.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.67 | $1.30 |
| 52 Week High | $22.57 | $2.98 |
Technical Indicators
Market Signals| Indicator | UPXI | INO |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 36.24 |
| Support Level | $1.97 | $1.47 |
| Resistance Level | $2.17 | $1.57 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 13.93 | 16.00 |
Price Performance
Historical ComparisonAbout UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.